Bell's palsy historical perspective
Bell's palsy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Bell's palsy historical perspective On the Web |
American Roentgen Ray Society Images of Bell's palsy historical perspective |
Risk calculators and risk factors for Bell's palsy historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Historical Perspective
Discovery
- The first comprehensive description of Bell's palsy was first discovered by Abū Bakr Muhammad ibn Zakariyyā al-Rāzī, a Persian polymath, physician, alchemist, philosopher, in 9th century, although Sir Charles Bell, a Scottish surgeon, was the first to provide the anatomic basis for the condition that bears his name in 1821.[1]
- For the fiest time, Razi provided accurate descriptions of facial muscles disorders.
- Razi describes a clinical method for distinguishing spasm and paralysis for the first time.
- Razi also gave the earliest description of bilateral facial palsy.
Landmark Events in the Development of Treatment Strategies
- In 9th century, the therapy of Bell's palsy was developed by Abū Bakr Muhammad ibn Zakariyyā al-Rāzī.
- The treatment given by Razi was:
- Massage until the “skin turns red,”
- Warming oils and ointments
- Warm compresses
- Inhaled and intranasal medicines (emphasis on inducing sneezing)
- Oral medications (emphasis on gargling)
- Special diets
- Phlebotomy
- Application of a bandage to the distorted area to counteract the unbridled pull of the muscles
- In 1821, Sir Charles Bell described the lesions of the seventh cranial nerve produce facial paralysis.[2]
- Bell described the Bell's palsy is caused by problem of 7th cranial nerve(facial nerve).
References
- ↑ Sajadi MM, Sajadi MR, Tabatabaie SM (2011). "The history of facial palsy and spasm: Hippocrates to Razi". Neurology. 77 (2): 174–8. doi:10.1212/WNL.0b013e3182242d23. PMC 3140075. PMID 21747074.
- ↑ Grzybowski A, Kaufman MH (2007). "Sir Charles Bell (1774-1842): contributions to neuro-ophthalmology". Acta Ophthalmol Scand. 85 (8): 897–901. doi:10.1111/j.1600-0420.2007.00972.x. PMID 17680840.